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httpcense.Abstract Back ground: Community acquired pneumonia (CAP) is recognized as a common prob-
lem that carries a substantial morbidity and mortality. The burden of disease falls mainly on people
at the extremes of age and while the occurrence of CAP in young adults is uncommon. Nevertheless,
pneumonia in young adults can be severe and fatal. Pneumonia in the pregnant patient is the most
frequent cause of fatal non-obstetric infection.
Aim of the work: The aim of this study was to assess the pattern of community acquired pneu-
monia among pregnant ladies in Ain Shams University hospitals.
Patients and method: The present study included 168 pregnant ladies with community acquired
pneumonia, who were selected from out patient’s clinics of obstetrics and gynecology department,
Ain Shams University (ASUH).
Results: The present study included 168 pregnant ladies with community acquired pneumonia,
who were selected from out patient’s clinics of obstetrics and gynecology department, Ain Shams
University (ASUH). Their ages ranged from 18–42 years old with mean age of 25.32 years old
(±4.20 SD).
Conclusion: Morbidity and mortality in pregnant patients with pneumonia continue to present a
signiﬁcant challenge. Early recognition of the diseases process and prompt treatment are required to
ascertain an optimal outcome. The treatments in the gravid patients generally follow standard guide
lines for the treatment of pneumonia in adults. Concern for fetal outcome should not delay treat-
ment as improvement in maternal oxygenation and status is the best way to ensure fetal protection.
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Community acquired pneumonia (CAP) is recognized as a
common problem that carries a substantial morbidity and
mortality. The burden of disease falls mainly on people at
the extremes of age and the occurrence of CAP in young adultsis. Production and hosting by Elsevier B.V.
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356 A.M. Abdel Dayem et al.is uncommon [24] and Adel et al. [1]. Nevertheless, pneumonia
in young adults can be severe and fatal [27]. Pneumonia in the
pregnant patient, is the most frequent cause of fatal non-
obstetric infection [16].
Alterations in cellular immunity have been widely reported
and are aimed primarily at protecting the fetus from the
mother. These changes include decreased lymphocyte prolifer-
ative response, especially in the second and third trimesters,
decreased natural killer cell activity, changes in T cell popula-
tions with a decrease in numbers of circulating helper T cells,
reduced lymphocyte cytotoxic activity, and production by
the trophoblast of substances that could block maternal recog-
nition of fetal major histocompatibility antigens [4].
The difﬁculties in diagnosis during pregnancy reﬂect the
complexity of distinguishing between symptoms related to
physiological changes and more sinister symptoms of disease.
Patients themselves may attribute symptoms of pneumonia
to pregnancy and hence defer consultation. Chest discomfort
may also occur in the later stages of pregnancy, possibly due
to the mechanical effects of the uterus on the diaphragm. It
may be difﬁcult to distinguish it from other causes of chest dis-
comfort [7].
Aim of the work
The aim of this study was to assess the pattern of community
acquired pneumonia among pregnant ladies in Ain Shams
University hospitals
Patients and methods
The present study included 168 pregnant ladies with commu-
nity acquired pneumonia, who were selected from out patient’s
clinics of obstetrics and gynecology department, Ain Shams
University hospitals (ASUH).
All the patients were subjected to the following:
1. History taking: The diagnosis of CAP which was done in
the out patients clinics of the chest department ASUH
and was based on the presence of selected clinical features
(e.g., cough, fever, sputum production, dyspnea, and pleu-
ritic chest pain) and was supported by imaging of the lung,
(chest radiography).
2. Thorough clinical examination: Both general and local
examination of the chest which were done in the chest
department ASUH to establish the diagnosis of community
acquired pneumonia and to exclude any other chest
diseases.
3. Plain chest X-ray (CXR): A chest radiograph was required
for the routine evaluation of patients who were likely to
have pneumonia, to establish the diagnosis. But, It is esti-
mated that radiation doses to the mother from a standard
departmental posteroanterior chest radiograph, performed
with a grid to reduce scatter and a peak voltage for the
beam of 90–120 kV, is 5–30 m Rad. The absorbed dose
for the uterus and fetus is 100 times less (about 300 l Rad).
A lateral chest radiograph results in greater exposure
(maternal dose 150–250 m Rad) and was not usually
required [3].
4. Laboratory Investigations: It was done in clinical and
chemical department ASUH. Complete blood picture usingauto mated coulter, total leucocytes count, (TLC), hemo-
globin concentration. Blood ﬁlm to demonstrate differen-
tial white blood cells count (WBCs) and morphology of
red blood cells (RBCs), Erythrocyte sedimentation rate
(ESR) using Western Green method. Liver function test
(alanin transaminase (ALT), aspartate transaminase
(AST), alkaline phosphatase (ALP)-total and direct biliru-
bin- total proteins and albumin-gamma glutamines
(GGT).Kidney function test, (creatinine and urea)Fasting
blood sugar, Post prandial (2 h) blood sugar.
5. Microbiological investigations: They were performed in
Microbiology and Immunology department, faculty of
medicine. Ain Shams University (ASU).
A. Pretreatment sputum samples were obtained from all
patients. Good quality samples (having fewer than 10 squa-
mous epithelial cells and more than 25 neutrophils per low
power ﬁeld) are subjected to the followings:
1-Direct smear stained with Gram stain and Ziehl Neelsen
stain (to detect acid fast bacilli).
2-Aerobic culture for bacteria using conventional culture
media: blood agar, chocolate agar, MacConkey agar and
Lowenstein Jensen media.
3-PCR to detect nucleic acids of Chlamydia pneumoniae and
Mycoplasma pneumoniae.
B. Urine samples were obtained from all patients to detect
Legionella pneumophila Ag using DFA (Direct ﬂuorescent
ab) test.
Ethical aspects
The study was explained to the pregnant patients and their
husbands giving them a clear idea about the investigations
done to them and that they have the right to withdraw from
the study at any time.
Statistical methods
All data were collected, summarized, and analyzed by using an
appropriate statistical package program (SPSS, 13). For quan-
titative data which were normally distributed and summarized
by mean and standard deviation. For qualitative data were
summarized by number and percentage.
Results
The present study included 168 pregnant ladies with commu-
nity acquired pneumonia, who were selected from out patient’s
clinics of obstetrics and gynecology department, Ain Shams
University hospitals (ASUH).Their ages ranged from 18–
42 years old with mean age of 25.32 years old (±4.20 SD).
As regarded history taking of the 168 pregnant ladies, there
was 121 cases complaining of fever (72.2%), cough was present
in 151 cases (89.9%), sputum production was present in 112
cases (66.66%), dyspnea was present in 111 cases (66.6%),
pleuritic chest pain was present in 59 cases (35.11%), and
non respiratory complains in the form of nausea, vomiting,
myalgia and headache was found in 65 cases (38.69%)
(Table 1).
Table 1 Demographic data for the pregnant ladies with CAP.
Variable Number Percent %
History C/O
Fever 121/168 72.02
Cough 151/168 89.98
Sputum 112/168 66.66
Dyspnea 111/168 66.07
Pleuritic chest pain 59/168 35.11
Non respiratory complains 65/168 38.69
Associated diseases
Asthma 9/168 5.35
Anemia 99/168 58.92
Tocolytic agents 26/168 15.47
Chest X ray
Normal 71/168 42.26
Pulmonary inﬁltrate 51/168 30.35
Atelectasis 16/168 9.52
Pleural eﬀusion 4/168 2.38
Pneumonitis 11/168 6.54
Pulmonary oedema 15/168 8.92
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mia was detected in 99 cases (58.92%).There was 26 cases
using tocolytic agents because of obstetric problems in present-
ing 15.47%.
Chest X ray radiography was done in all cases to establish
the diagnosis and to exclude any other chest diseases. Within
normal CXR was present in 71 cases (42.26%), pulmonary
inﬁltrate was found in 51 cases (30.35%), atelectasis was de-
tected in 16 cases (9.52%),pleural effusion was found in four
cases which was mild (2.38%), pneumonitis was detected in
11 cases (6.54%), and 15 cases of pulmonary oedema
(8.92%) (Table 1).
Table 2 shows that Streptococcus pneumonia in 55 cases
(32.74%) was the most common organism followed by Hae-
mophilus inﬂuenza in 35 cases (20.83%), M. pneumonia in 20
cases (11.90%), Staphylococous in 15 cases (8.93%), Chlam-
lydophila pneumonia in 13 cases (7.74%), L. pneumophilia in
14 cases (8.33%), Klebsiella pneumonia in 3 cases (1.79%),
Pseudomonus aerugenosa in 1 cases (0.60%), Mycobacterium
tuberculosis (TB) was not found in any cases (0.00%), And
in 12 cases of microbiological analysis showed No bacteriolog-
ical agent (7.14%).Table 2 Prevalence of organisms found in studied CAP in
pregnant ladies.
Organism Number of cases Prevalence %
Streptococcus pneumonia 55 32.74
Haemophilus inﬂuenza 35 20.83
Mycoplasma pneumonia 20 11.90
Staphylococous 15 8.93
Chlamlydophila pneumonia 13 7.74
Leigonella pneumophilia 14 8.33
Klebsiella pneumonia 3 1.79
Pseudomonas aeruginosa 1 0.60
Mycobacterium tuberculosis (TB) 0 0.00
No bacteriological agent 12 7.14
Total 168 100.00Discussion
Community acquired pneumonia (CAP) is recognized as a
common problem that carries a substantial morbidity and
mortality. The burden of disease falls mainly on people at
the extremes of age and the occurrence of CAP in young adults
is uncommon. Nevertheless, pneumonia in young adults can be
severe and fatal [27]. Pneumonia the pregnant patient, pneu-
monia is the most frequent cause of fatal non-obstetric infec-
tion [16,13].
Alterations in cellular immunity have been widely reported
and are aimed primarily at protecting the fetus from the
mother. These changes include decreased lymphocyte prolifer-
ative response, especially in the second and third trimesters,
decreased natural killer cell activity, changes in T cell popula-
tions with a decrease in numbers of circulating helper T cells,
reduced lymphocyte cytotoxic activity, and production by
the trophoblast of substances that could block maternal recog-
nition of fetal major histocompatibility antigens [4,22].
In addition, hormones prevalent during pregnancy-includ-
ing progesterone, human chorionic gonadotropin, alpha-feto-
protein and cortisol-may inhibit cell mediated immune
function. These changes could theoretically increase the risk
from infection, particularly by viral and fungal pathogens [17].
Mortality of 5.7% was reported in a BTS multicentre study
of hospitalized adults aged 16–74 years compared with 0–1% in
young ambulatory adults with CAP. Mortality from pneumo-
nia in pregnancy is similar to rates in non-pregnant adults [18].
There is persuasive evidence to indicate that fetal outcome
is affected by maternal pneumonia. Mothers with pneumonia
are signiﬁcantly more likely to deliver before 34 weeks gesta-
tion, with preterm delivery occurring in up to 43% of cases
Prostaglandin production or the host’s inﬂammatory response
to infection may be responsible [5]. In addition, infants had
born to mothers with pneumonia weight signiﬁcantly less.
One study found a difference of 150 g in the birth weight of in-
fants born to mothers with pneumonia compared with con-
trols. Similarly, the frequency of low birth weight infants
(2500 g or less) was higher in cases than in controls (16% vs.
8%) [10]. There is no ﬁrm evidence of any difference in perina-
tal mortality based on studies conducted over the last two dec-
ades. Mothers with pneumonia are more likely to deliver early
and have infants of lower birth weight than other pregnant wo-
men [30].
The present study included 168 pregnant ladies with com-
munity acquired pneumonia, who were selected from out pa-
tient’s clinics of obstetrics and gynecology department, Ain
Shams University hospitals (ASUH).Their ages ranged from
18–42 years old with mean age of 25.32 years old (±4.20 SD).
As regarded history taking of the 168 pregnant ladies, there
was121 cases complaining of fever (72.2%), cough was present
in 151 cases (89.9%), sputum production was present in 112
cases (66.66%), dyspnea was present in 111 cases (66.6%),
pleuritic chest pain was present in 59 cases (35.11%), and
non respiratory complains in the form of nausea, vomiting,
myalgia and headache was found in 65 cases (38.69%).
In agreement with Halm and Teristein [12], who stated that,
the evaluation of community acquired pneumonia is initiated
based on patients symptoms of bacterial pneumonia in preg-
nancy are the same as in nonpregnant individuals. Mild upper
respiratory complains preceding symptoms that include cough
358 A.M. Abdel Dayem et al.in more than 90%,sputum production in 66%,dyspnea in 66%
and pleuritic chest pain 50%, and non respiratory symptoms
including headache, fatigue, myalgia, sweat and nausea. Also
Kasper et al. [15], stated that, clinical symptoms of pneumonia
including fever, cough, pleuritic chest pain, rigors, chills, and
dyspnea. During pregnancy 59.3% of patients reported cough,
32.2% shortness of breath and 27.1% reported pleuritic chest
pain.
Maternal asthma was found in nine cases (3.39%) and ane-
mia was detected in 99 cases (58.92%). In agreement with [19]
reported that 24% of patients with patient’s antepartum pneu-
monia had an underlying maternal illness. And [21], maternal
asthma (odds ratio 5.3%) and anemia (odds ratio 9.9%) are
signiﬁcantly associated with the development during preg-
nancy. Briggs et al. [6] and also, [26], comorbid conditions such
as asthma, liver diseases, chronic obstructive pulmonary dis-
eases and pregnancy increase the susceptibility of pneumonia
and its complications Tarek et al. [28].
In our results, there were 26 cases using tocolytic agents be-
cause of obstetric problems presenting 15.47%. Munn et al.
[21], said that, tocolytic agents given to induce labour have
been associated with the development of pneumonia. They also
increase the risk of respiratory insufﬁciency due to pneumonia
through the promotion of pulmonary oedema. It has therefore
been recommended that they are not used in pregnant patients
with pneumonia [14,25].
Chest X ray radiography was done in all cases to establish
the diagnosis and to exclude any other chest diseases. Within
normal CXR was present in 71 cases (42.26%),pulmonary
inﬁltrate was found in 51 cases (30.35%), atelectasis was de-
tected in 16 cases (9.52%),pleural effusion was found in four
cases which was mild (2.38%), pneumonitis was detected in
11 cases (6.54%), and 15 cases of pulmonary oedema
(8.92%). (Table 1) [21], demonstrated that, 98% of patients
with antipartum pneumonia had positive chest radiography
with ﬁnding inﬁltrate, atelctasis, pleural effusion, pneumonitis
or pulmonary edema. Also [26], stated that CXR performed in
patients in whom pneumonia is suspected lobar consolidation,
cavitations and pleural effusion are shown in typical bacterial
lobar pneumonia [29,8].
Our results showed that, S. pneumonia in 55 cases (32.74%)
was the most common organism followed by H. inﬂuenza in 35
cases (20.83%), M. pneumonia in 20 cases (11.90%), Staphylo-
cocous in 15 cases (8.93%), C. pneumonia in 13 cases (7.74%),
Legionella pneumophilia in 14 cases (8.33%), K. pneumonia in
3 cases (1.79%), P. aerugenosa in 1 cases (0.60%), M. tubercu-
losis (TB) was not found in any cases (0.00%), And in 12 cases
of microbiological analysis showed No bacteriological agent
(7.14%). In agreement with Lim et al., 2003, who found the
most common bacterial agent identiﬁed in pregnancy include
streptococcus pneumonia in 17% of cases and H. inﬂuenza
identiﬁed in6% of cases. Also in agreement with [11] who found
the most common single pathogen is streptococcus pneumonia
which is responsible for 30–50% of identiﬁed cases followed by
H. inﬂuenza andM. pneumonia. But [23,9], foundM. pneumonia
is another common cause of pneumonia in pregnancy [20,2].Conclusion
Morbidity and mortality in pregnant patients with pneumonia
continue to present a signiﬁcant challenge. Early recognition ofthe diseases process and prompt treatment is required to cer-
tain an optimal outcome. The treatments in the gravid patients
generally follow standard guide lines for the treatment of
pneumonia in adults. Although concern for fetal outcome
should not delay treatment as improvement in maternal oxy-
genation and status is the best way to ensure that fetus will
be protected.
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